Your browser doesn't support javascript.
loading
COVID-19 in patients with hepatobiliary and pancreatic diseases: a single-centre cross-sectional study in East London.
Dayem Ullah, Abu Z M; Sivapalan, Lavanya; Kocher, Hemant M; Chelala, Claude.
Afiliação
  • Dayem Ullah AZM; Centre for Cancer Biomarker and Biotherapeutics, Barts Cancer Institute, London, UK d.ullah@qmul.ac.uk.
  • Sivapalan L; Barts and the London HPB Centre, The Royal London Hospital, Barts Health NHS Trust, London, UK.
  • Kocher HM; Centre for Cancer Biomarker and Biotherapeutics, Barts Cancer Institute, London, UK.
  • Chelala C; Barts and the London HPB Centre, The Royal London Hospital, Barts Health NHS Trust, London, UK.
BMJ Open ; 11(4): e045077, 2021 04 19.
Article em En | MEDLINE | ID: mdl-33875444
ABSTRACT

OBJECTIVE:

To explore risk factors associated with COVID-19 susceptibility and survival in patients with pre-existing hepato-pancreato-biliary (HPB) conditions.

DESIGN:

Cross-sectional study.

SETTING:

East London Pancreatic Cancer Epidemiology (EL-PaC-Epidem) Study at Barts Health National Health Service Trust, UK. Linked electronic health records were interrogated on a cohort of participants (age ≥18 years), reported with HPB conditions between 1 April 2008 and 6 March 2020.

PARTICIPANTS:

EL-PaC-Epidem Study participants, alive on 12 February 2020, and living in East London within the previous 6 months (n=15 440). The cohort represents a multi-ethnic population with 51.7% belonging to the non-White background. MAIN OUTCOME

MEASURE:

COVID-19 incidence and mortality.

RESULTS:

Some 226 (1.5%) participants had confirmed COVID-19 diagnosis between 12 February and 12 June 2020, with increased odds for men (OR 1.56; 95% CI 1.2 to 2.04) and Black ethnicity (2.04; 1.39 to 2.95) as well as patients with moderate to severe liver disease (2.2; 1.35 to 3.59). Each additional comorbidity increased the odds of infection by 62%. Substance misusers were at more risk of infection, so were patients on vitamin D treatment. The higher ORs in patients with chronic pancreatic or mild liver conditions, age >70, and a history of smoking or obesity were due to coexisting comorbidities. Increased odds of death were observed for men (3.54; 1.68 to 7.85) and Black ethnicity (3.77; 1.38 to 10.7). Patients having respiratory complications from COVID-19 without a history of chronic respiratory disease also had higher odds of death (5.77; 1.75 to 19).

CONCLUSIONS:

In this large population-based study of patients with HPB conditions, men, Black ethnicity, pre-existing moderate to severe liver conditions, six common medical multimorbidities, substance misuse and a history of vitamin D treatment independently posed higher odds of acquiring COVID-19 compared with their respective counterparts. The odds of death were significantly high for men and Black people.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pancreatopatias / COVID-19 / Hepatopatias Tipo de estudo: Etiology_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pancreatopatias / COVID-19 / Hepatopatias Tipo de estudo: Etiology_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article